Security
USANA Health Sciences Inc · USNA
USNANYSECommon stockCurrentCIK 896264Updated Nov 14, 2026
Name history
USANA INC · through Apr 27, 2000
USNA price & chart
Loading TradingView…
NYSE:USNA on TradingView ↗About the company
USANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Brand Partners and Preferred Customers across 25 global markets. More information on USANA can be found at www.usana.com. USANA also owns a 78.8% controlling ownership stake in Hiya Health Products, a children's health and wellness company, and a 100% interest in Rise Wellness. Hiya and Rise Wellness offer a variety of clean-label health products. More information on Hiya can be found at www.hiyahealth.com. More information on Rise Wellness can be found at www.risebar.com and www.proteinpop.com.
In the news
USANA Foundation Shares Holiday Cheer with Meals for Utah Students and Families News provided by USANA Dec 23, 2025, 06:52 ET Share this article Share to X Share this article Share to X More than 5,100 food bags delivered to help support children during winter break SALT LAKE CITY , Dec. 23, 2025 /P ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
SCHEDULE 13G/A - filed by RENAISSANCE TECHNOLOGIES LLC regarding USANA HEALTH SCIENCES INC
10-Q filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 726,591,000Source | 671,308,000Source | 703,210,000Source | 734,526,000Source | 631,419,000Source | 738,966,000Source | 746,596,000Source | 629,275,000Source | 742,915,000Source | 748,193,000Source | 632,757,000Source | 596,549,000Source |
| Property, Plant and Equipment, NetUSD | 96,212,000Source | 98,033,000Source | 94,269,000Source | 96,532,000Source | 97,686,000Source | 94,625,000Source | 94,245,000Source | 98,186,000Source | 94,383,000Source | 94,565,000Source | 99,814,000Source | 97,773,000Source |
| GoodwillUSD | 144,288,000Source | 17,196,000Source | 109,141,000Source | 144,230,000Source | 16,837,000Source | 138,127,000Source | 144,218,000Source | 16,902,000Source | 137,962,000Source | 144,168,000Source | 17,102,000Source | 17,368,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 138,159,000Source | 29,237,000Source | 124,615,000Source | 142,747,000Source | 28,637,000Source | 128,901,000Source | 147,157,000Source | 29,105,000Source | 133,151,000Source | 151,823,000Source | 29,919,000Source | 32,432,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 145,349,000Source | 364,889,000Source | 168,560,000Source | 151,338,000Source | 332,423,000Source | 162,751,000Source | 179,613,000Source | 328,336,000Source | 158,380,000Source | 181,768,000Source | 330,420,000Source | 288,420,000Source |
| Inventory, NetUSD | 90,781,000Source | 63,984,000Source | 86,343,000Source | 83,269,000Source | 61,832,000Source | 96,358,000Source | 73,557,000Source | 60,870,000Source | 102,608,000Source | 69,735,000Source | 61,454,000Source | 67,089,000Source |
| Assets, CurrentUSD | 264,065,000Source | 451,191,000Source | 281,066,000Source | 261,866,000Source | 419,081,000Source | 294,233,000Source | 281,394,000Source | 421,070,000Source | 288,405,000Source | 279,187,000Source | 417,746,000Source | 384,382,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 27,935,000Source | 22,318,000Source | 22,826,000Source | 27,259,000Source | 24,826,000Source | 25,467,000Source | 28,224,000Source | 31,864,000Source | 27,417,000Source | 27,684,000Source | 25,872,000Source | 28,873,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | — | — | — | — | — | — | — | 22,954,000Source | 21,177,000Source | 17,671,000Source | 19,997,000Source |
| Other Assets, NoncurrentUSD | 59,710,000Source | 58,828,000Source | 64,580,000Source | 62,716,000Source | 50,988,000Source | 57,921,000Source | 60,739,000Source | 52,665,000Source | 61,805,000Source | 58,806,000Source | 54,892,000Source | 54,795,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 145,038,000Source | — | 132,237,000Source | 148,968,000Source | — | 144,180,000Source | 162,723,000Source | — | 156,643,000Source | 161,861,000Source | 135,555,000Source | — |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 18,000Source | 19,000Source | 18,000Source | 18,000Source | 19,000Source | 18,000Source | 19,000Source | 19,000Source | 18,000Source | 19,000Source | 19,000Source | 19,000Source |
| Retained Earnings (Accumulated Deficit)USD | 467,495,000Source | 474,490,000Source | 451,853,000Source | 474,017,000Source | 463,883,000Source | 473,235,000Source | 477,628,000Source | 453,451,000Source | 465,720,000Source | 478,944,000Source | 445,217,000Source | 391,636,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -19,289,000Source | -13,699,000Source | -13,676,000Source | -19,349,000Source | -20,508,000Source | -14,436,000Source | -22,752,000Source | -18,593,000Source | -16,178,000Source | -22,670,000Source | -13,695,000Source | -12,787,000Source |
| Stockholders' Equity Attributable to ParentUSD | 528,074,000Source | 533,087,000Source | 526,306,000Source | 531,060,000Source | 512,208,000Source | 543,550,000Source | 529,762,000Source | 499,988,000Source | 533,104,000Source | 532,109,000Source | 497,202,000Source | 434,472,000Source |
| Additional Paid in Capital, Common StockUSD | 79,850,000Source | 72,277,000Source | 88,111,000Source | 76,374,000Source | 68,814,000Source | 84,733,000Source | 74,867,000Source | 65,111,000Source | 83,544,000Source | 75,816,000Source | 65,661,000Source | 55,604,000Source |
| Liabilities and EquityUSD | 726,591,000Source | 671,308,000Source | 703,210,000Source | 734,526,000Source | 631,419,000Source | 738,966,000Source | 746,596,000Source | 629,275,000Source | 742,915,000Source | 748,193,000Source | 632,757,000Source | 596,549,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 118,664,000Source | 114,779,000Source | 105,675,000Source | 121,625,000Source | 103,896,000Source | 117,239,000Source | 137,383,000Source | 112,631,000Source | 128,565,000Source | 139,625,000Source | 118,845,000Source | 143,833,000Source |
| Operating Lease, Liability, CurrentUSD | — | — | — | — | — | — | — | — | 5,650,000Source | 6,013,000Source | 7,278,000Source | 6,892,000Source |
| Accounts Payable, CurrentUSD | 16,219,000Source | 7,041,000Source | 15,431,000Source | 17,899,000Source | 6,648,000Source | 16,230,000Source | 13,974,000Source | 8,266,000Source | 17,263,000Source | 11,984,000Source | 10,070,000Source | 11,049,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | — | — | — | — | — | — | 12,306,000Source | 10,191,000Source | 5,141,000Source | 7,680,000Source |
| Deferred Income Tax Liabilities, NetUSD | 4,467,000Source | 4,727,000Source | 4,662,000Source | 4,662,000Source | 4,653,000Source | 5,057,000Source | 4,801,000Source | 5,113,000Source | 4,892,000Source | 4,073,000Source | 4,552,000Source | 4,071,000Source |
| Other Liabilities, NoncurrentUSD | 21,907,000Source | 18,715,000Source | 21,900,000Source | 22,681,000Source | 10,662,000Source | 21,884,000Source | 20,539,000Source | 11,543,000Source | 23,186,000Source | 18,163,000Source | 12,158,000Source | 14,173,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | — | — | — | — | — | — | — | — | 9,500,000Source | 13,569,000Source | 9,750,000Source | — |
| Deferred Revenue, CurrentUSD | — | — | — | — | — | — | — | — | — | — | 13,910,000Source | 20,875,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 23,579,000Source | 27,913,000Source | — | — |
| Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD | 53,479,000Source | — | 44,667,000Source | 54,498,000Source | — | 51,236,000Source | 54,111,000Source | — | 53,168,000Source | 54,223,000Source | 0Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -6,662,000Source | 10,607,000Source | -27,951,000Source | 10,444,000Source | 6,959,000Source | 9,290,000Source | 11,477,000Source | 42,060,000Source | 63,788,000Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 7,919,000Source | 3,569,000Source | 7,674,000Source | 7,743,000Source | 8,277,000Source | 8,339,000Source | 32,562,000Source | 14,539,000Source | 12,702,000Source | 13,393,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 3,454,000Source | 2,880,000Source | 13,828,000Source | 14,558,000Source | 14,595,000Source | 13,331,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -6,597,000Source | 4,921,000Source | 34,685,000Source | 2,118,000Source | -2,353,000Source | -21,879,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -1,459,000Source | 1,975,000Source | 5,204,000Source | -1,269,000Source | -428,000Source | -2,656,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -7,136,000Source | -6,738,000Source | -2,675,000Source | -6,937,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 9,759,000Source | 15,482,000Source | 22,349,000Source | 60,992,000Source | 70,641,000Source | 103,902,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | 0Source | 203,336,000Source | 0Source | 6,532,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -2,597,000Source | -3,875,000Source | -10,125,000Source | -213,090,000Source | -11,975,000Source | -12,370,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 2,645,000Source | 2,803,000Source | 13,823,000Source | 10,073,000Source | 14,494,000Source | 10,400,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 2,265,000Source | 2,167,000Source | 2,347,000Source | 3,223,000Source | 3,092,000Source | 4,706,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 0Source | 12,300,000Source | 27,507,000Source | 9,444,000Source | 11,599,000Source | 25,382,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -3,641,000Source | -14,467,000Source | -40,603,000Source | 9,553,000Source | -14,237,000Source | -30,088,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 4,417,000Source | -2,141,000Source | -23,268,000Source | -148,738,000Source | 41,926,000Source | 47,667,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 148,153,000Source | 367,741,000Source | 171,508,000Source | 154,126,000Source | 165,657,000Source | 182,367,000Source | 161,240,000Source | 184,508,000Source | 333,246,000Source | 291,320,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 242,000Source | 52,000Source | 663,000Source | 76,000Source | 68,000Source | 49,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 37,180,000Source | 40,395,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | 14,009,000Source | 14,779,000Source | — | — |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 19,318,000Source | 1,516,000Source | 1,835,000Source | 1,723,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 13,841,000Source | 13,152,000Source | 10,904,000Source | 11,351,000Source |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | -13,000Source | 0Source | 2,093,000Source | -1,000Source | -10,000Source | -141,000Source |
| GoodwillUSD | — | — | 144,288,000Source | 17,196,000Source | 109,141,000Source | 144,230,000Source | 138,127,000Source | 144,218,000Source | 137,962,000Source | 144,168,000Source | 17,102,000Source | 17,368,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | 6,967,000Source | 0Source | — | — |
| Goodwill, Impairment LossUSD | — | — | 0Source | 0Source | 29,137,000Source | 0Source | — | — | 6,527,000Source | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | — | — |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | 0Source | 0Source | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | 8,456,000Source | 8,001,000Source | 9,051,000Source | 8,373,000Source | 8,506,000Source | 7,449,000Source | 30,050,000Source | 34,291,000Source | 38,665,000Source | 39,271,000Source |
| InterestExpenseNonoperatingUSD | — | — | 49,000Source | 49,000Source | 0Source | 259,000Source | 240,000Source | 411,000Source | 842,000Source | 281,000Source | 262,000Source | — |
| Inventory Write-downUSD | — | — | — | — | — | — | 1,299,000Source | 1,211,000Source | 2,679,000Source | 1,891,000Source | 2,601,000Source | — |
| Investment Income, InterestUSD | — | — | 578,000Source | 3,142,000Source | 595,000Source | 619,000Source | 437,000Source | 723,000Source | 2,415,000Source | 11,319,000Source | 9,637,000Source | 3,789,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -6,522,000Source | 10,607,000Source | -21,382,000Source | 9,655,000Source | 7,515,000Source | 9,402,000Source | 10,760,000Source | 42,030,000Source | 63,788,000Source | 69,350,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | 10,607,000Source | — | — | — | — | — | — | 63,788,000Source | 69,350,000Source |
| Nonoperating Income (Expense)USD | — | — | 570,000Source | 3,007,000Source | 1,096,000Source | 2,099,000Source | 1,591,000Source | 1,068,000Source | 4,095,000Source | 10,027,000Source | 9,382,000Source | 1,007,000Source |
| Operating ExpensesUSD | — | — | 163,631,000Source | 145,363,000Source | 194,930,000Source | 168,946,000Source | 176,908,000Source | 181,423,000Source | 686,973,000Source | 626,967,000Source | 651,246,000Source | 697,097,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 8,323,000Source | 8,191,000Source | 8,755,000Source | 8,258,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 41,000Source | -86,000Source | 501,000Source | 1,739,000Source | 1,394,000Source | 756,000Source | 2,522,000Source | -1,011,000Source | 7,000Source | -2,590,000Source |
| Increase (Decrease) in Accounts Receivable | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Derivative, Gain (Loss) on Derivative, Net | — | — | — | — | — | —Source | — | — | — | — | — | — |
| Unrealized Gain (Loss) on Derivatives | — | — | — | — | — | — | — | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 213,670,000Source | 200,221,000Source | 223,273,000Source | 235,848,000Source | 250,218,000Source | 249,539,000Source | 925,257,000Source | 854,503,000Source | 921,010,000Source | 998,601,000Source |
| Cost of RevenueUSD | — | — | 48,815,000Source | 39,257,000Source | 48,339,000Source | 50,184,000Source | 59,436,000Source | 52,445,000Source | 200,852,000Source | 161,212,000Source | 176,693,000Source | 193,890,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 85,947,000Source | 61,295,000Source | 82,318,000Source | 81,906,000Source | 88,254,000Source | 91,438,000Source | 337,372,000Source | 263,268,000Source | 256,989,000Source | 262,304,000Source |
| Operating Income (Loss)USD | — | — | 1,224,000Source | 15,601,000Source | -19,996,000Source | 16,718,000Source | 13,874,000Source | 15,671,000Source | 37,432,000Source | 66,324,000Source | 93,071,000Source | 107,614,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 41,000Source | -86,000Source | 501,000Source | 1,739,000Source | 1,394,000Source | 756,000Source | 2,522,000Source | -1,011,000Source | 7,000Source | -2,590,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 1,794,000Source | 18,608,000Source | -18,900,000Source | 18,817,000Source | 15,465,000Source | 16,739,000Source | 41,527,000Source | 76,351,000Source | 102,453,000Source | 108,621,000Source |
| Income Tax Expense (Benefit)USD | — | — | 8,456,000Source | 8,001,000Source | 9,051,000Source | 8,373,000Source | 8,506,000Source | 7,449,000Source | 30,050,000Source | 34,291,000Source | 38,665,000Source | 39,271,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -6,522,000Source | 10,607,000Source | -21,382,000Source | 9,655,000Source | 7,515,000Source | 9,402,000Source | 10,760,000Source | 42,030,000Source | 63,788,000Source | 69,350,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.36Source | 0.56Source | -1.16Source | 0.52Source | 0.41Source | 0.49Source | 0.58Source | 2.2Source | 3.31Source | 3.6Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.36Source | 0.56Source | -1.16Source | 0.52Source | 0.41Source | 0.49Source | 0.58Source | 2.19Source | 3.3Source | 3.59Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 18,293,000Source | 19,078,000Source | 18,486,000Source | 18,513,000Source | 18,398,000Source | 19,049,000Source | 18,535,000Source | 19,103,000Source | 19,250,000Source | 19,254,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 18,293,000Source | 19,083,000Source | 18,486,000Source | 18,536,000Source | 18,411,000Source | 19,085,000Source | 18,574,000Source | 19,162,000Source | 19,345,000Source | 19,310,000Source |
| Interest Expense (non-operating)USD | — | — | 49,000Source | 49,000Source | 0Source | 259,000Source | 240,000Source | 411,000Source | 842,000Source | 281,000Source | 262,000Source | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 19,318,000Source | 1,516,000Source | 1,835,000Source | 1,723,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 37,186,000Source | 41,029,000Source | 41,340,000Source | 46,208,000Source |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | 0Source | 29,137,000Source | 0Source | — | — | 6,527,000Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | — | — | 164,855,000Source | 160,964,000Source | 174,934,000Source | 185,664,000Source | 190,782,000Source | 197,094,000Source | 724,405,000Source | 693,291,000Source | 744,317,000Source | 804,711,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -56,248,000Source | -35,274,000Source | -19,988,000Source | -23,996,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 262,000Source | 192,000Source |
| Investment Income, InterestUSD | — | — | 578,000Source | 3,142,000Source | 595,000Source | 619,000Source | 437,000Source | 723,000Source | 2,415,000Source | 11,319,000Source | 9,637,000Source | 3,789,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | 10,607,000Source | — | — | — | — | — | — | 63,788,000Source | 69,350,000Source |
| Nonoperating Income (Expense)USD | — | — | 570,000Source | 3,007,000Source | 1,096,000Source | 2,099,000Source | 1,591,000Source | 1,068,000Source | 4,095,000Source | 10,027,000Source | 9,382,000Source | 1,007,000Source |
| Operating ExpensesUSD | — | — | 163,631,000Source | 145,363,000Source | 194,930,000Source | 168,946,000Source | 176,908,000Source | 181,423,000Source | 686,973,000Source | 626,967,000Source | 651,246,000Source | 697,097,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 8,323,000Source | 8,191,000Source | 8,755,000Source | 8,258,000Source |
| Other IncomeUSD | — | — | 744,000Source | 512,000Source | 424,000Source | 566,000Source | 482,000Source | 498,000Source | 2,302,000Source | 2,356,000Source | 3,177,000Source | 3,452,000Source |
| Research and Development ExpenseUSD | — | — | — | — | — | — | — | — | 10,693,000Source | 11,571,000Source | 11,446,000Source | 11,563,000Source |
Filing attachments
q32026earningsreleaseex991.htm · 8-K · 2026-11-03
USANA Health Sciences Reports Third Quarter 2026 Results Hiya Active Monthly Subscribers Increase 18% Sequentially; Core Nutritional Operating Margin Expands; Company Generates $36 Million in Year-to-Date Free Cash Flow SALT LAKE CITY, November 3, 2026 (BUSINESS WIRE) - USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended October 3, 2026. Key Financial Results Third Quarter 2026 vs. Third Quarter 2025 • Net sales of $206 million versu…
Read attachment ↗q22026earningsreleaseex991.htm · 8-K · 2026-08-04
EX-99.1 2 q22026earningsreleaseex991.htm EX-99.1 Document USANA Health Sciences Reports Second Quarter 2026 Results Company Continues Evolution to a Diversified, Omnichannel Health and Wellness Business SALT LAKE CITY, August 4, 2026 (BUSINESS WIRE) - USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended July 4, 2026. Key Financial Results Second Quarter 2026 vs. Second Quarter 2025 • Net sales of $223 million versus $236 million…
Read attachment ↗q12026earningsreleaseex991.htm · 8-K · 2026-05-05
EX-99.1 2 q12026earningsreleaseex991.htm EX-99.1 Document USANA Health Sciences Reports First Quarter 2026 Results Company Continues to Make Significant Progress on Transformation to Becoming a Leading Omnichannel Health and Wellness Platform SALT LAKE CITY, May 5, 2026 (BUSINESS WIRE) - USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended April 4, 2026. Key Financial Results First Quarter 2026 vs. First Quarter 2025 • Net sales …
Read attachment ↗q42025earningsreleaseex991.htm · 8-K · 2026-02-18
USANA Health Sciences Reports Fourth Quarter and Full Year 2025 Results and Provides Fiscal Year 2026 Outlook SALT LAKE CITY, February 17, 2026 (BUSINESS WIRE) - USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and fiscal year ended January 3, 2026. Key Financial and Operating Results Q4 2025 Q4 2024 FY 2025 FY 2024 ────────────────────────────────────────────────────────────────────…
Read attachment ↗q22025earningsreleaseex991.htm · 8-K · 2025-07-22
EX-99.1 2 q22025earningsreleaseex991.htm EX-99.1 Document USANA Health Sciences Reports Second Quarter 2025 Results and Reiterates Full-Year Outlook SALT LAKE CITY, July 22, 2025 (BUSINESS WIRE) - USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 28, 2025. Key Financial Results Second Quarter 2025 vs. Second Quarter 2024 • Net sales of $236 million versus $213 million, representing 11% year-over-year growth. • Net earnin…
Read attachment ↗q12025earningsreleaseex991.htm · 8-K · 2025-04-22
EX-99.1 2 q12025earningsreleaseex991.htm EX-99.1 Document USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook SALT LAKE CITY, April 22, 2025 (BUSINESS WIRE) - USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended March 29, 2025. Key Financial Results First Quarter 2025 vs. First Quarter 2024 • Net sales of $250 million versus $228 million, representing year-over-year growth of 10% and 12% in co…
Read attachment ↗